[Figure: see text].

Department of Biomedical Statistics and Informatics Mayo Clinic College of Medicine Rochester MN

Department of Cardiovascular Diseases Mayo Clinic College of Medicine Rochester MN

Department of Laboratory Medicine and Pathology Mayo Clinic College of Medicine Rochester MN

International Clinical Research Center

Zobrazit více v PubMed

Collaborators GBDCoD. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392:1736–1788. PubMed PMC

Dawber TR, Kannel WB and McNamara PM. The Prediction of Coronary Heart Disease. Trans Assoc Life Insur Med Dir Am 1964;47:70–105. PubMed

Kannel WB, Dawber TR, Friedman GD, Glennon WE and McNamara PM. Risk Factors in Coronary Heart Disease. An Evaluation of Several Serum Lipids as Predictors of Coronary Heart Disease; the Framingham Study. Ann Intern Med 1964;61:888–99. PubMed

Prospective Studies C, Lewington S, Whitlock G, Clarke R, Sherliker P, Emberson J, Halsey J, Qizilbash N, Peto R and Collins R. Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet. 2007;370:1829–39. PubMed

Emerging Risk Factors C, Di Angelantonio E, Sarwar N, Perry P, Kaptoge S, Ray KK, Thompson A, Wood AM, Lewington S, Sattar N, Packard CJ, Collins R, Thompson SG and Danesh J. Major lipids, apolipoproteins, and risk of vascular disease. JAMA. 2009;302:1993–2000. PubMed PMC

Wilson PW, D’Agostino RB, Levy D, Belanger AM, Silbershatz H and Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97:1837–47. PubMed

Arnett DK, Blumenthal RS, Albert MA, et al. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol 2019;74:1376–1414. PubMed PMC

DeFilippis AP, Young R and Blaha MJ. Calibration and Discrimination Among Multiple Cardiovascular Risk Scores in a Modern Multiethnic Cohort. Ann Intern Med 2015;163:68–9. PubMed

Borodzicz S, Czarzasta K, Kuch M and Cudnoch-Jedrzejewska A. Sphingolipids in cardiovascular diseases and metabolic disorders. Lipids Health Dis 2015;14:55. PubMed PMC

Laaksonen R, Ekroos K, Sysi-Aho M, et al. Plasma ceramides predict cardiovascular death in patients with stable coronary artery disease and acute coronary syndromes beyond LDL-cholesterol. Eur Heart J 2016;37:1967–76. PubMed PMC

Meeusen JW, Donato LJ, Bryant SC, Baudhuin LM, Berger PB and Jaffe AS. Plasma Ceramides. Arterioscler Thromb Vasc Biol 2018;38:1933–1939. PubMed

Peterson LR, Xanthakis V, Duncan MS, Gross S, Friedrich N, Volzke H, Felix SB, Jiang H, Sidhu R, Nauck M, Jiang X, Ory DS, Dorr M, Vasan RS and Schaffer JE. Ceramide Remodeling and Risk of Cardiovascular Events and Mortality. J Am Heart Assoc 2018;7. PubMed PMC

Havulinna AS, Sysi-Aho M, Hilvo M, Kauhanen D, Hurme R, Ekroos K, Salomaa V and Laaksonen R. Circulating Ceramides Predict Cardiovascular Outcomes in the Population-Based FINRISK 2002 Cohort. Arterioscler Thromb Vasc Biol 2016;36:2424–2430. PubMed

Ammar KA, Jacobsen SJ, Mahoney DW, Kors JA, Redfield MM, Burnett JC Jr. and Rodeheffer RJ. Prevalence and prognostic significance of heart failure stages: application of the American College of Cardiology/American Heart Association heart failure staging criteria in the community. Circulation. 2007;115:1563–70. PubMed

St Sauver JL, Grossardt BR, Yawn BP, Melton LJ 3rd, Pankratz JJ, Brue SM and Rocca WA. Data resource profile: the Rochester Epidemiology Project (REP) medical records-linkage system. Int J Epidemiol 2012;41:1614–24. PubMed PMC

Rocca WA, Yawn BP, St Sauver JL, Grossardt BR and Melton LJ 3rd. History of the Rochester Epidemiology Project: half a century of medical records linkage in a US population. Mayo Clin Proc 2012;87:1202–13. PubMed PMC

Redfield MM, Rodeheffer RJ, Jacobsen SJ, Mahoney DW, Bailey KR and Burnett JC Jr. Plasma brain natriuretic peptide concentration: impact of age and gender. J Am Coll Cardiol 2002;40:976–82. PubMed

Melton LJ 3rd. History of the Rochester Epidemiology Project. Mayo Clin Proc 1996;71:266–74. PubMed

Kauhanen D, Sysi-Aho M, Koistinen KM, Laaksonen R, Sinisalo J and Ekroos K. Development and validation of a high-throughput LC-MS/MS assay for routine measurement of molecular ceramides. Anal Bioanal Chem 2016;408:3475–83. PubMed

Sigruener A, Kleber ME, Heimerl S, Liebisch G, Schmitz G and Maerz W. Glycerophospholipid and sphingolipid species and mortality: the Ludwigshafen Risk and Cardiovascular Health (LURIC) study. PLoS One. 2014;9:e85724. PubMed PMC

Wang DD, Toledo E, Hruby A, et al. Plasma Ceramides, Mediterranean Diet, and Incident Cardiovascular Disease in the PREDIMED Trial (Prevencion con Dieta Mediterranea). Circulation. 2017;135:2028–2040. PubMed PMC

Meeusen JW, Donato LJ, Kopecky SL, Vasile VC, Jaffe AS and Laaksonen R. Ceramides improve atherosclerotic cardiovascular disease risk assessment beyond standard risk factors. Clin Chim Acta 2020;511:138–142. PubMed

Kurz J, Parnham MJ, Geisslinger G and Schiffmann S. Ceramides as Novel Disease Biomarkers. Trends Mol Med 2019;25:20–32. PubMed

Chatterjee SB, Dey S, Shi WY, Thomas K and Hutchins GM. Accumulation of glycosphingolipids in human atherosclerotic plaque and unaffected aorta tissues. Glycobiology. 1997;7:57–65. PubMed

Park TS, Panek RL, Mueller SB, Hanselman JC, Rosebury WS, Robertson AW, Kindt EK, Homan R, Karathanasis SK and Rekhter MD. Inhibition of sphingomyelin synthesis reduces atherogenesis in apolipoprotein E-knockout mice. Circulation. 2004;110:3465–71. PubMed

Hojjati MR, Li Z, Zhou H, Tang S, Huan C, Ooi E, Lu S and Jiang XC. Effect of myriocin on plasma sphingolipid metabolism and atherosclerosis in apoE-deficient mice. J Biol Chem 2005;280:10284–9. PubMed

Grundy SM, Stone NJ, Bailey AL, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;139:e1082–e1143. PubMed PMC

DeFilippis AP and Blaha MJ. Predicted vs Observed Clinical Event Risk for Cardiovascular Disease. JAMA. 2015;314:2082. PubMed

Nanna MG, Peterson ED, Wojdyla D and Navar AM. The Accuracy of Cardiovascular Pooled Cohort Risk Estimates in U.S. Older Adults. J Gen Intern Med 2019. PubMed PMC

Blaha MJ, Mortensen MB, Kianoush S, Tota-Maharaj R and Cainzos-Achirica M. Coronary Artery Calcium Scoring: Is It Time for a Change in Methodology? JACC Cardiovasc Imaging. 2017;10:923–937. PubMed

Forbang NI, McClelland RL, Remigio-Baker RA, Allison MA, Sandfort V, Michos ED, Thomas I, Rifkin DE and Criqui MH. Associations of cardiovascular disease risk factors with abdominal aortic calcium volume and density: The Multi-Ethnic Study of Atherosclerosis (MESA). Atherosclerosis. 2016;255:54–58. PubMed PMC

Leber AW, Knez A, White CW, Becker A, von Ziegler F, Muehling O, Becker C, Reiser M, Steinbeck G and Boekstegers P. Composition of coronary atherosclerotic plaques in patients with acute myocardial infarction and stable angina pectoris determined by contrast-enhanced multislice computed tomography. Am J Cardiol 2003;91:714–8. PubMed

Bergman BC, Brozinick JT, Strauss A, Bacon S, Kerege A, Bui HH, Sanders P, Siddall P, Kuo MS and Perreault L. Serum sphingolipids: relationships to insulin sensitivity and changes with exercise in humans. Am J Physiol Endocrinol Metab 2015;309:E398–408. PubMed PMC

Ng TW, Ooi EM, Watts GF, Chan DC, Weir JM, Meikle PJ and Barrett PH. Dose-dependent effects of rosuvastatin on the plasma sphingolipidome and phospholipidome in the metabolic syndrome. J Clin Endocrinol Metab 2014;99:E2335–40. PubMed

Tarasov K, Ekroos K, Suoniemi M, Kauhanen D, Sylvanne T, Hurme R, Gouni-Berthold I, Berthold HK, Kleber ME, Laaksonen R and Marz W. Molecular lipids identify cardiovascular risk and are efficiently lowered by simvastatin and PCSK9 deficiency. J Clin Endocrinol Metab 2014;99:E45–52. PubMed PMC

Hilvo M, Meikle PJ, Pedersen ER, et al. Development and validation of a ceramide- and phospholipid-based cardiovascular risk estimation score for coronary artery disease patients. Eur Heart J 2020;41:371–380. PubMed

The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators. Am J Epidemiol 1989;129:687–702. PubMed

Fried LP, Borhani NO, Enright P, Furberg CD, Gardin JM, Kronmal RA, Kuller LH, Manolio TA, Mittelmark MB, Newman A and et al. The Cardiovascular Health Study: design and rationale. Ann Epidemiol 1991;1:263–76. PubMed

Friedman GD, Cutter GR, Donahue RP, Hughes GH, Hulley SB, Jacobs DR Jr., Liu K and Savage PJ. CARDIA: study design, recruitment, and some characteristics of the examined subjects. J Clin Epidemiol 1988;41:1105–16. PubMed

Lipidomic Profiling Identifies Signatures of Poor Cardiovascular Health